269 related articles for article (PubMed ID: 11909953)
1. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
[TBL] [Abstract][Full Text] [Related]
2. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
[TBL] [Abstract][Full Text] [Related]
3. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
[TBL] [Abstract][Full Text] [Related]
4. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
[TBL] [Abstract][Full Text] [Related]
5. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
Yeo C; Whitman M
Mol Cell; 2001 May; 7(5):949-57. PubMed ID: 11389842
[TBL] [Abstract][Full Text] [Related]
6. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
Gray PC; Harrison CA; Vale W
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
[TBL] [Abstract][Full Text] [Related]
7. Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.
D'Andrea D; Liguori GL; Le Good JA; Lonardo E; Andersson O; Constam DB; Persico MG; Minchiotti G
J Cell Biol; 2008 Feb; 180(3):597-605. PubMed ID: 18268105
[TBL] [Abstract][Full Text] [Related]
8. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
[TBL] [Abstract][Full Text] [Related]
9. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
Bianco C; Normanno N; De Luca A; Maiello MR; Wechselberger C; Sun Y; Khan N; Adkins H; Sanicola M; Vonderhaar B; Cohen B; Seno M; Salomon D
J Cell Physiol; 2002 Jan; 190(1):74-82. PubMed ID: 11807813
[TBL] [Abstract][Full Text] [Related]
10. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
[TBL] [Abstract][Full Text] [Related]
11. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
Kumar A; Novoselov V; Celeste AJ; Wolfman NM; ten Dijke P; Kuehn MR
J Biol Chem; 2001 Jan; 276(1):656-61. PubMed ID: 11024047
[TBL] [Abstract][Full Text] [Related]
12. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
13. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
Reissmann E; Jörnvall H; Blokzijl A; Andersson O; Chang C; Minchiotti G; Persico MG; Ibáñez CF; Brivanlou AH
Genes Dev; 2001 Aug; 15(15):2010-22. PubMed ID: 11485994
[TBL] [Abstract][Full Text] [Related]
14. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.
Klauzinska M; Castro NP; Rangel MC; Spike BT; Gray PC; Bertolette D; Cuttitta F; Salomon D
Semin Cancer Biol; 2014 Dec; 29():51-8. PubMed ID: 25153355
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
16. Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development.
Andersson O; Bertolino P; Ibáñez CF
Dev Biol; 2007 Nov; 311(2):500-11. PubMed ID: 17936261
[TBL] [Abstract][Full Text] [Related]
17. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.
Harms PW; Chang C
Genes Dev; 2003 Nov; 17(21):2624-9. PubMed ID: 14563676
[TBL] [Abstract][Full Text] [Related]
18. Cell-type specific regulation of myostatin signaling.
Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
[TBL] [Abstract][Full Text] [Related]
19. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor.
Watanabe K; Hamada S; Bianco C; Mancino M; Nagaoka T; Gonzales M; Bailly V; Strizzi L; Salomon DS
J Biol Chem; 2007 Dec; 282(49):35772-86. PubMed ID: 17925387
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion.
Sakuma R; Ohnishi Yi Y; Meno C; Fujii H; Juan H; Takeuchi J; Ogura T; Li E; Miyazono K; Hamada H
Genes Cells; 2002 Apr; 7(4):401-12. PubMed ID: 11952836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
